VPIM
BHVN

Vanguard Personalized Indexing Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,248
Closed -$945K – 1380
2022
Q3 		$945K Sell
6,248
-79
-1% -$11.7K 0.04% 505
2022
Q2 		$922K Buy
6,327
+2,947
+87% +$376K 0.04% 506
2022
Q1 		$401K Buy
3,380
+735
+28% +$91.7K 0.02% 914
2021
Q4 		$365K Buy
2,645
+370
+16% +$47.1K 0.02% 812
2021
Q3 		$316K Buy
+2,275
New +$284K 0.03% 744

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Vanguard Personalized Indexing Management's BHVN Position: Q4 2022 in Review

Vanguard Personalized Indexing Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 6,248 shares — an estimated $945K sold.

Vanguard Personalized Indexing Management first reported a position in BHVN in Q3 2021 and held it in 5 quarters. The position peaked at $945K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Vanguard Personalized Indexing Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 6,248 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $945K.
  • Vanguard Personalized Indexing Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2021 and held it in 5 quarters.
  • Vanguard Personalized Indexing Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $945K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2022, filed 10 Feb 2023.